Intermountain Healthcare—Days of Using Coolers to Transport Organs May Soon Be Over

In this article, Intermountain Healthcare transplant surgeons perform the first ever liver transplants in Utah with organs preserved by the LifePort® Liver Transporter during the clinical trial, PILOT. PILOT (Perfusion to Improve Liver Outcomes in Transplantation) is a prospective randomized multi-center oxygenated hypothermic machine perfusion study using the LifePort Liver Transporter (LLT) system with Vasosol as compared to static cold storage in orthotopic liver transplantation.

.

 

“The primary objective of this study is to collect clinical data to provide reasonable assurance of safe and effective use of transporting livers for our transplant patients,” said Dr. Diane Alonso. “In the long run, we hope to use this technology in the future to increase the number of organs available for transplantation, while reducing complications and shortening the length of hospital stays.”

Intermountain Healthcare is a not-for-profit health system with a team of more than 41,000 caregivers based in Salt Lake City, Utah who serve the healthcare needs of people across Utah, Idaho, and Nevada.

Tagged In:

The Latest

Check out the most recent posts

Fox19—UC Health Performs First Cold Pump Liver Transplant

In this article from FOX19 NOW, meet the first liver transplant patient to receive a cold pump liver which was pumped on a LifePort® Liver Transporter during its clinical trial, PILOT™. PILOT (Perfusion to Improve Liver Outcomes in Transplantation) is a...

ABC12 News—Organ Transplant Goes Hi-tech

In this article, Intermountain Healthcare takes part in the PILOT™ clinical trial of the LifePort® Liver Transporter. PILOT (Perfusion to Improve Liver Outcomes in Transplantation) is a prospective randomized multi-center oxygenated hypothermic machine...

KSLTV—Doctors Testing New Liver Transplant Transport System

In this article, KSLTV of Salt Lake City reports on Intermountain Healthcare’s participation in the LifePort Liver Transporter clinical trial. “We’re keeping that liver working in a somewhat normal, physiologic state during the time that it’s out of the donor’s body...